Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE Study.
Mellemkjaer L, Dahl C, Olsen JH, Bertelsen L, Guldberg P, Christensen J, Børresen-Dale AL, Stovall M, Langholz B, Bernstein L, Lynch CF, Malone KE, Haile RW, Andersson M, Thomas DC, Concannon P, Capanu M, Boice JD Jr; WECARE Study Collaborative Group; Bernstein JL.
Mellemkjaer L, et al.
Br J Cancer. 2008 Feb 26;98(4):728-33. doi: 10.1038/sj.bjc.6604228. Epub 2008 Feb 5.
Br J Cancer. 2008.
PMID: 18253122
Free PMC article.